Splash Pharmaceuticals

About:

Splash Pharmaceuticals is a clinical stage oncology company.

Website: http://www.splashpharma.com/

Top Investors: Solstice Capital, Hamilton BioVentures

Description:

Splash is a privately held company that is developing novel cancer therapies with a goal to provide dramatic and durable responses in many solid tumors. Splash has developed a pipeline of novel agents that target CD44 with demonstrated anti-angiogenic and anti-metastatic activity as well as synergistic cytotoxicity with other chemotherapy agents. Splash is actively seeking Pharma partners to accelerate its novel clinical programs.

Total Funding Amount:

$23M

Headquarters Location:

San Diego, California, United States

Founded Date:

2001-01-01

Founders:

David Nelson

Number of Employees:

1-10

Last Funding Date:

2018-05-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai